(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug

Source: Yonhap ·

(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug

SEOUL, Nov. 5 (Yonhap) -- SK Biopharmaceuticals Co., a biopharmaceutical arm of ...

Read the full story at Yonhap

Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.

More from the world desk